Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05789082 |
|---|---|
| Brief Title: | A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation (Krascendo 170) |
| First Submitted : | February 21, 2023 |
| First Submitted that Met QC Criteria : | March 28, 2023 |
| First Posted : | March 29, 2023 |
| Last Update Submitted that Met QC Criteria : | May 14, 2024 |
| Last Update Posted : | May 16, 2024 |